Jennifer Lachey - Chief Scientific Officer at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jennifer Lachey since 9/17/2023

Holdings reported by Jennifer Lachey for Keros Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 95.1K $4.31M $45.29 Jul 15, 2022 Direct
of Shares Employee Stock Option (right to buy) 76.7K Apr 4, 2022 Direct Common Stock
Employee Stock Option (right to buy) 8.76K Jul 15, 2022 Direct Common Stock

Transactions reported by Jennifer Lachey for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.